ABBOTT LABORATORIES - Common Stock (ABT)

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Number of holders
1801
Total 13F shares, excl. options
1,254,589,153
Shares change
-15,732,041
Total reported value, excl. options
$76,508,542,840
Value change
-$964,494,217
Put/Call ratio
64.61%
Number of buys
689
Number of sells
-860
Price
$60.99

Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2018

1,925 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q2 2018.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,801 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,254,589,153 shares of 1,740,239,592 outstanding shares and own 72.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (136,803,540 shares), Capital Research Global Investors (131,099,788 shares), BlackRock Inc. (116,149,740 shares), STATE STREET CORP (67,180,598 shares), WELLINGTON MANAGEMENT GROUP LLP (41,733,161 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (39,138,499 shares), NORTHERN TRUST CORP (26,094,797 shares), MORGAN STANLEY (21,218,276 shares), WELLS FARGO & COMPANY/MN (20,322,141 shares), and GEODE CAPITAL MANAGEMENT, LLC (19,996,903 shares).
This table shows the top 1801 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.